These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27324921)

  • 1. Exclusion criteria in treatment research on alcohol, tobacco and illicit drug use disorders: A review and critical analysis.
    Moberg CA; Humphreys K
    Drug Alcohol Rev; 2017 May; 36(3):378-388. PubMed ID: 27324921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DSM-5 substance use disorders among adult primary care patients: Results from a multisite study.
    Wu LT; McNeely J; Subramaniam GA; Brady KT; Sharma G; VanVeldhuisen P; Zhu H; Schwartz RP
    Drug Alcohol Depend; 2017 Oct; 179():42-46. PubMed ID: 28753480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in the substance use disorder exclusion criterion in antidepressant efficacy trials.
    Zimmerman M; Clark HL; Multach MD; Walsh E; Rosenstein LK; Gazarian D
    J Affect Disord; 2016 Jul; 198():39-42. PubMed ID: 27002283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of exclusion criteria in selecting research subjects and its effect on the generalizability of alcohol treatment outcome studies.
    Humphreys K; Weisner C
    Am J Psychiatry; 2000 Apr; 157(4):588-94. PubMed ID: 10739418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Academy of Pediatrics. Committee on Substance Abuse. Tobacco, alcohol, and other drugs: the role of the pediatrician in prevention and management of substance abuse.
    American Academy of Pediatrics. Committee on Substance Abuse
    Pediatrics; 1998 Jan; 101(1 Pt 1):125-8. PubMed ID: 11345974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of enrolment eligibility criteria in alcohol treatment outcome research: generalisability and potential bias in 1- and 6-year outcomes.
    Storbjörk J
    Drug Alcohol Rev; 2014 Nov; 33(6):604-11. PubMed ID: 25303086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management, substitutive therapy and withdrawal: tobacco, alcohol, psycho-active and illicit substances. Tobacco addiction].
    Dansou A; Maino B; Lemarié E
    Rev Prat; 2012 Jun; 62(6):837-41. PubMed ID: 22838288
    [No Abstract]   [Full Text] [Related]  

  • 8. Participant exclusion criteria in treatment research on neurological disorders: Are unrepresentative study samples problematic?
    Trivedi RB; Humphreys K
    Contemp Clin Trials; 2015 Sep; 44():20-25. PubMed ID: 26188162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of Eligibility Criteria on the Generalizability of Alcohol and Drug Treatment Outcome Research: A Study of Real-World Treatment Seekers in Sweden and in Australia.
    Storbjörk J; Garfield JB; Larner A
    Subst Use Misuse; 2017 Mar; 52(4):439-450. PubMed ID: 27849416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tobacco use and illicit substance use disorders: what should we have to do?].
    Karila L; Petit A; Zarmdini R; Coscas S; Lowenstein W; Reynaud M
    Presse Med; 2013 May; 42(5):795-805. PubMed ID: 23528335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological Treatment of Youth Substance Use Disorders.
    Squeglia LM; Fadus MC; McClure EA; Tomko RL; Gray KM
    J Child Adolesc Psychopharmacol; 2019 Aug; 29(7):559-572. PubMed ID: 31009234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency department screening and interventions for substance use disorders.
    Hawk K; D'Onofrio G
    Addict Sci Clin Pract; 2018 Aug; 13(1):18. PubMed ID: 30078375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The representation of females in clinical trials for substance use disorder conducted in the United States (2010-19).
    Gunn CM; Pankowska M; Harris M; Helsing E; Battaglia TA; Bagley SM
    Addiction; 2022 Oct; 117(10):2583-2590. PubMed ID: 35165969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exclusion of participants based on substance use status: Findings from randomized controlled trials of treatments for PTSD.
    Leeman RF; Hefner K; Frohe T; Murray A; Rosenheck RA; Watts BV; Sofuoglu M
    Behav Res Ther; 2017 Feb; 89():33-40. PubMed ID: 27846419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Attention-deficit/hyperactivity disorder and substance abuse].
    Davids E; Gastpar M
    Psychiatr Prax; 2003 May; 30(4):182-6. PubMed ID: 12768521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and brief intervention for alcohol and other abuse.
    Harris SK; Louis-Jacques J; Knight JR
    Adolesc Med State Art Rev; 2014 Apr; 25(1):126-56. PubMed ID: 25022191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of screening, brief intervention, and referral to treatment in the perinatal period.
    Wright TE; Terplan M; Ondersma SJ; Boyce C; Yonkers K; Chang G; Creanga AA
    Am J Obstet Gynecol; 2016 Nov; 215(5):539-547. PubMed ID: 27373599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individuals receiving specialized treatment for drug and alcohol dependence and gambling disorder in Israel--characteristics and implications for prevalence estimates.
    Lev-Ran S; Florentin I; Feingold D; Rehm J
    Subst Abus; 2014; 35(3):268-75. PubMed ID: 24779614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance use treatment needs among recent veterans.
    Eggleston AM; Straits-Tröster K; Kudler H
    N C Med J; 2009; 70(1):54-8. PubMed ID: 19534058
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between substance use and body mass index in young males.
    Blüml V; Kapusta N; Vyssoki B; Kogoj D; Walter H; Lesch OM
    Am J Addict; 2012; 21(1):72-7. PubMed ID: 22211349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.